Ubs Oconnor LLC Pacific Biosciences Of California, Inc. Transaction History

Ubs Oconnor LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $23.4 Million - $28.3 Million	-5,078,991 Closed	0 $0
Q3 2019 Nov 12, 2020	BUY	$4.99 - $6.16 $1.48 Million - $1.82 Million	296,262 Added 6.19%	5,078,991 $26.2 Million
Q2 2019 May 15, 2020	BUY	$5.92 - $7.41 $28.3 Million - $35.4 Million	4,782,729 New	4,782,729 $0
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $35.9 Million - $44.9 Million	-6,064,035 Closed	0 $0
Q1 2019 May 15, 2020	BUY	$6.8 - $7.4 $41.2 Million - $44.9 Million	6,064,035 New	6,064,035 $0
Q1 2019 May 13, 2019	SELL	$6.8 - $7.4 $20.4 Million - $22.2 Million	-2,996,814 Closed	0 $0
Q4 2018 Aug 14, 2019	BUY	$3.99 - $7.82 $12 Million - $23.4 Million	2,996,814 New	2,996,814 $22.2 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.